|
Alzheimer's disease
Compiled
By:
Joe Hing Kwok Chu
Neuropathology
of human Alzheimer disease after immunization with amyloid-beta peptide:
a case report.
Division
of Clinical Neurosciences, University of Southampton, Southampton, UK. J.Nicoll@soton.ac.uk
Amyloid-beta peptide (Abeta) has a key role in the pathogenesis of Alzheimer
disease (AD). Immunization with Abeta in a transgenic mouse model of AD
reduces both age-related accumulation of Abeta in the brain and associated
cognitive impairment. Here we present the first analysis of human neuropathology
after immunization with Abeta (AN-1792). Comparison with unimmunized cases
of AD (n = 7) revealed the following unusual features in the immunized case,
despite diagnostic neuropathological features of AD: (i) there were extensive
areas of neocortex with very few Abeta plaques; (ii) those areas of cortex
that were devoid of Abeta plaques contained densities of tangles, neuropil
threads and cerebral amyloid angiopathy (CAA) similar to unimmunized AD,
but lacked plaque-associated dystrophic neurites and astrocyte clusters;
(iii) in some regions devoid of plaques, Abeta-immunoreactivity was associated
with microglia; (iv) T-lymphocyte meningoencephalitis was present; and (v)
cerebral white matter showed infiltration by macrophages. Findings (i)-(iii)
strongly resemble the changes seen after Abeta immunotherapy in mouse models
of AD and suggest that the immune response generated against the peptide
elicited clearance of Abeta plaques in this patient. The T-lymphocyte meningoencephalitis
is likely to correspond to the side effect seen in some other patients who
received AN-1792 (refs. 7-9).
PMID: 12640446
[PubMed - indexed for MEDLINE]
Explanation
of the above treatise by
Joe Hing Kwok Chu
:
Amyloid-beta peptide: is
an antimicrobial peptide. It is a precursor of
beta-amyloid.
beta-amyloidis, a starch-like
protein which can helps eliminate infection but can also damage the healthy
brain cells. Aβ ( beta-amyloid)
plays a key role in the cause of Alzheimer's disease. Aβ can adjust itself
to a variety of environmental stressors, and able to induce pro-inflammatory
activities.[2]
Immunization with
an A-beta vaccine in
mice that were genetically induced Alzheimer's disease reduces the age -related
accumulation of
beta-amyloid in the brain
and associated cognitive impairment.
The
researchers immunized a human patient with A-beta
vaccine, using the drug called AN-1792.
(
N-1792 was
developed to stimulate the immune system to "recognize" and attack
the amyloid plaques that are a characteristics of Alzheimer brain abnormality).
Compared to 7 un-immunized cases,
it was found that despite the diagnostic sickness of the nerves/brain
of Alzheimer's disease:
-
there were extensive areas
of the top layer of the brain hemispheres
(neocortex) with
very few
A-beta
(beta-amyloid)
plaques;
-
those areas of cortex that
were devoid of A-beta plaques contained densities of
tangles, neuropil
threads and
cerebral
amyloid angiopathy (CAA) similar to unimmunized AD, but lacked plaque-associated
dystrophic (degenerated)
neurites and
astrocyte clusters;
-
in some regions devoid of plaques,
Abeta-immunoreactivity was associated with
microglia;
-
T-lymphocyte meningoencephalitis
(inflammation of the brain and the membrane) was present; and
-
cerebral white matter showed
infiltration by macrophages (large white cells that defend against bacteria
and other foreign matters)..
Findings (1)-(3) strongly resemble
the changes seen after A-beta immunotherapy in mouse models of AD and suggest
that the immune response generated against the peptide elicited clearance
of A-beta plaques in this patient. The T-lymphocyte meningoencephalitis
is likely to correspond to the side effect seen in some other patients who
received AN-1792.
Neuropil
is the nervous tissue consisting of a fibrous network of nonmyelinated
nerve fibers; gray matter with few nerve cell bodies; usually a region of
synapses between axons and dendrites. (click
here to go back)
Cerebral amyloid angiopathy
(CAA) is also known as congophilic angiopathy or cerebrovascular
amyloidosis. It is a disease of small blood vessels in the brain in
which deposits of amyloid protein in the vessel walls may lead to
stroke, brain hemorrhage, or
dementia. Amyloid protein resembles a starch and is deposited in tissues
during the course of certain chronic diseases. (answers.com) (click
here to go back)
Microglia
is any of the small neuroglial cells of the central nervous system having
long processes and
amoeboid and
phagocytic activity
at sites of neural damage or inflammation. (click
here to go back)
Neocortex
is the top layer of the brain hemispheres that handles conscious thought
and language. It is also called neopallium ("new mantle") and isocortex
("equal rind"). (click
here to go back)
Neurites:
Any projection from the
cell body of a
neuron can be referred to as a neurite. This projection can be
either an
axon or a
dendrite. The term is frequently used when speaking of immature or developing
neurons, especially of cells in
culture, because it can be difficult to tell axons from dendrites in
that situation. (answers.com) (click
here to go back)
Amoeboid:
characteristics of resembling an amoeba, like in changeability of
form and means of locomotion. (Click
here to go back)
A-beta (
beta-amyloid) plaques: Are precipitations
protein lumps inside and outside the nerve cells caused by abnormal protein-protein
interactions. These abnormal interactions of protein play a role in
the dysfunction and death of nerve cells in diseases such as Alzheimer’s
disease and Parkinson’s disease . (click
here to go back)
Links:
A beta peptide vaccination
prevents memory loss in an animal model of Alzheimer's disease.
http://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&uid=11140686&cmd=showdetailview&indexed=google
http://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&uid=12640446&cmd=showdetailview&indexed=google
Nat
Med. 2003 Apr;9(4):448-52. Epub 2003 Mar 17.
Links
- Comment in:
-
Nat Med. 2003 Apr;9(4):389-90.
-
Nat Med. 2004 Feb;10(2):117-8; author reply 118-9.
-
- Also see: herb on memory
loss due to AchE over active:
- 1. Chinese herb
qian ceng ta;
and
- 2. common herb Spanish sage
-
-
A Potential
Treatment (from Shanghai)
-
- Stimulating β2-adrenergic
receptor ( β2腎上腺素受體)
can increase the activity of γ-Secretase (γ-分
泌酶)and can cause the increase of the production of Amyloid beta-Protein
(Aβ) (β澱粉樣蛋白). This discovery shows a possible cause of Alzheimer's disease
and therefore γ-secretase is potential target for the
treatment of Alzheimer's disease. [1]
-
-
中國科學院上海生命科學研究院生物化學與細胞生物學研究所裴鋼院士領導的研究小組經多年研究後發現,β2腎上腺素受體被激活後,可增強γ分泌酶的活性,進
而能夠增加導致阿爾茨海默病的β澱粉樣蛋白的產生。該發現揭示了阿爾茨海默病致病的新機制,並且提示β2腎上腺素受體有可能成為研發阿爾茨海默病治療藥物
的新靶點。11月19日,國際著名學術期刊《自然·醫學》網絡版在線發表了這項關於β澱粉樣蛋白產生過程新機制的最新研究成果。
[1] Reported by Pei Gang et al of Bio-chemistry and Cell
Biology Department of Shanghai Life Science Research Institute of Science
Institute of China. Natural Medicine, 2007, Nov 10.
Compiler's note: Stimulating β2-adrenergic receptor increases epinephrine
and norepinephrine secretion. Example of drug that stimulates β2-adrenergic
receptor: Salmeterol is a long-acting β2-adrenergic receptor
(β2AR) agonist commonly used in the treatment of asthma and chronic
obstructive pulmonary disease. Salmeterol is one of the 2 ingredients of
Advair. See some of
other β2 agonists.
Diagnosis
Note:
EEG (electroencephalogram):
a graphical record of electrical activity of the brain; produced by an electroencephalograph
From reports of various studies,
it can be concluded that Alzheimer's disease is caused by beta-amyloid.
See a another study here:
Pro-NGF Can Be Related to Its Increased Oxidative Modifications in Alzheimer
Disease
Moderately increased homocysteine levels as well as decreased folate and
vitamin B12
levels have been associated with Alzheimer's disease and vascular
dementia.
[1]
More on Abeta (beta-amyloid)
Back to
causes of memory loss.
[2]http://www.plosone.org/article/info:doi/10.1371/journal.pone.0009505
Below are Sponsors' Ads by Google 以
下為谷歌所提供之廣告
|